Single-Cell Analysis – News and Features

Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has announced the expansion of its international commercial operations.

BD Biosciences has developed a method with the potential to transform both single cell transcriptional profiling and high parameter proteomics

Scientists at the Wellcome - MRC Cambridge Stem Cell Instituteopens in new window have used cutting-edge technology to profile over 20,000 individual cells to produce the first ‘cell map’ describing all the major cell types present at the early stage of mammalian embryo development.

Researchers at the University of Zurich have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Patients for whom therapy does not work can thus be treated using different methods at an earlier stage.

Microfluidics has rapidly grown in popularity over the last few years, as indicated by the sky-rocketing number of publications featuring microfluidic applications. We caught up with Mark Gilligan, CEO and founder of Dolomite Microfluidics, to discuss the latest developments in microfluidics and how the company is positioning itself to support future developments.

Marine bacteria that live in the dark depths of the ocean play a newly discovered and significant role in the global carbon cycle, according to a new study.

€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project.

First prize awarded to two PhD candidates from Johns Hopkins University in Baltimore, Maryland.

A study led by Kevin King, a bioengineer and physician at the University of California San Diego, has found that the immune system plays a surprising role in the aftermath of heart attacks.

From the initial vision of re-creating entire chemistry laboratories on chips, microfluidics has evolved into niche applications for cell culture and analytical science.